Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simonet

Showing results (1031-1040 of 1,089) with videos related to

Pageof 109
Sort By:
Bone|May 30, 2006
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopeniaJi Li, Ildiko Sarosi, Russell C Cattley, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 5, 2011
Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bonesMichael S Ominsky, Chaoyang Li, Xiaodong Li, et al.
American Journal of Human Genetics|January 6, 2018
Rare Coding Variants in ANGPTL6 Are Associated with Familial Forms of Intracranial AneurysmRomain Bourcier, Solena Le Scouarnec, Stéphanie Bonnaud, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 4, 2008
Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosisXiaodong Li, Michael S Ominsky, Kelly S Warmington, et al.
European Journal of Human Genetics : EJHG|September 4, 2014
Fine-scale human genetic structure in Western FranceMatilde Karakachoff, Nicolas Duforet-Frebourg, Floriane Simonet, et al.
Annals of Neurology|August 5, 2022
Increased Phospho-AKT in Blood Cells from LRRK2 G2019S Mutation CarriersAlicia Garrido, Leticia Pérez-Sisqués, Cristina Simonet, et al.
Toxicologic Pathology|June 19, 2004
The candidate neuroprotective agent artemin induces autonomic neural dysplasia without preventing peripheral nerve dysfunctionBrad Bolon, Shuqian Jing, Frank Asuncion, et al.
Acta Neuropathologica|August 10, 2022
Severe congenital myasthenic syndromes caused by agrin mutations affecting secretion by motoneuronsArnaud Jacquier, Valérie Risson, Thomas Simonet, et al.
BMC Health Services Research|February 15, 2018
Prediction of post-acute care demand in medical and neurological inpatients: diagnostic assessment of the post-acute discharge score - a prospective cohort studyAntoinette Conca, Angela Gabele, Barbara Reutlinger, et al.
Archivos De Bronconeumologia|November 6, 2025
Update 2025 of the Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPDMarc Miravitlles, Myriam Calle, Jesús Molina, et al.
Pageof 109

Showing results (1031-1040 of 1,089) with videos related to

Sort By:
Pageof 109
Bone|May 30, 2006
Dkk1-mediated inhibition of Wnt signaling in bone results in osteopeniaJi Li, Ildiko Sarosi, Russell C Cattley, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|May 5, 2011
Inhibition of sclerostin by monoclonal antibody enhances bone healing and improves bone density and strength of nonfractured bonesMichael S Ominsky, Chaoyang Li, Xiaodong Li, et al.
American Journal of Human Genetics|January 6, 2018
Rare Coding Variants in ANGPTL6 Are Associated with Familial Forms of Intracranial AneurysmRomain Bourcier, Solena Le Scouarnec, Stéphanie Bonnaud, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 4, 2008
Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosisXiaodong Li, Michael S Ominsky, Kelly S Warmington, et al.
European Journal of Human Genetics : EJHG|September 4, 2014
Fine-scale human genetic structure in Western FranceMatilde Karakachoff, Nicolas Duforet-Frebourg, Floriane Simonet, et al.
Annals of Neurology|August 5, 2022
Increased Phospho-AKT in Blood Cells from LRRK2 G2019S Mutation CarriersAlicia Garrido, Leticia Pérez-Sisqués, Cristina Simonet, et al.
Toxicologic Pathology|June 19, 2004
The candidate neuroprotective agent artemin induces autonomic neural dysplasia without preventing peripheral nerve dysfunctionBrad Bolon, Shuqian Jing, Frank Asuncion, et al.
Acta Neuropathologica|August 10, 2022
Severe congenital myasthenic syndromes caused by agrin mutations affecting secretion by motoneuronsArnaud Jacquier, Valérie Risson, Thomas Simonet, et al.
BMC Health Services Research|February 15, 2018
Prediction of post-acute care demand in medical and neurological inpatients: diagnostic assessment of the post-acute discharge score - a prospective cohort studyAntoinette Conca, Angela Gabele, Barbara Reutlinger, et al.
Archivos De Bronconeumologia|November 6, 2025
Update 2025 of the Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPDMarc Miravitlles, Myriam Calle, Jesús Molina, et al.
Pageof 109